Medicare releases prices for first 10 drugs subject to negotiations

Medicare releases prices for first 10 drugs subject to negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and … Read more

Aaron Rodgers Regrets Saying He Was ‘Immunized’ Against COVID

Aaron Rodgers Regrets Saying He Was ‘Immunized’ Against COVID

NEW YORK (AP) — Aaron Rodgers says in a soon-to-be published book that he should have handled discussing his COVID-19 immunization status differently. The New York Jets quarterback was still with the Green Bay Packers in 2021 when he told reporters he was “immunized” against the virus — and then tested positive for COVID-19 three … Read more

U.S. consumer giants have one big sales problem: China

U.S. consumer giants have one big sales problem: China

Pictured here is a McDonald’s store in Yichang, Hubei province, China, on July 30, 2024. Nurphoto | Nurphoto | Getty Images BEIJING — A theme emerging in the latest slew of U.S. companies’ earnings reports is a drag from the China market. The Chinese economy — home to more than four times the population of … Read more

Drugmakers on new negotiated prices with Medicare

Drugmakers on new negotiated prices with Medicare

President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round of Medicare drug price negotiations has come … Read more

First Medicare drug price negotiations round nears end

First Medicare drug price negotiations round nears end

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round … Read more

Jim Cramer’s top 10 things to watch in the stock market Thursday

Jim Cramer’s top 10 things to watch in the stock market Thursday

My top 10 things to watch Thursday, July 18 1. Republican vice presidential nominee JD Vance attacked Wall Street in his speech Wednesday night at the Republic National Convention. Donald Trump’s running mate said the presidential hopeful “won’t cater to Wall Street.” He also blamed China for flooding the U.S. economy with “cheap foreign goods” … Read more

Roche alleges counterfeit diabetes medical devices were sold on Amazon

Roche alleges counterfeit diabetes medical devices were sold on Amazon

Roche Diabetes Care Inc. Accu-Chek brand glucose test strips are arranged for a photograph in the Brooklyn borough of New York, U.S., on Thursday, April 4, 2019.  Alex Flynn | Bloomberg | Getty Images Roche, one of the world’s largest biotech companies, said “dangerous counterfeits” of its diabetes medical devices ended up for sale on … Read more

AstraZeneca, drugmakers release promising cancer data

AstraZeneca, drugmakers release promising cancer data

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! I’m back in New York City after spending the last weekend in … Read more

Pfizer, Merck, J&J to release cancer drug data

Pfizer, Merck, J&J to release cancer drug data

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika, and I’ll be on the ground at the American … Read more

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

Johnson & Johnson will pay .5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

Johnson & Johnson on Wednesday said it will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer. The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.  More CNBC health coverage It … Read more